Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib

A. C. Tsai, C. Y. Wang, J. P. Liou, H. C. Pai, C. J. Hsiao, J. Y. Chang, J. C. Wang, C. M. Teng, S. L. Pan

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib'. Together they form a unique fingerprint.

Medicine & Life Sciences